Overview
- 8 inspections across 8 sites are on record.
- 20 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-09-29.
At a glance
Inspections
8
Sites
8
Observations
20
Career since
Jun 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Pharmaceutics International, Inc. | 29 Sep 2021 | Human Drugs | On file |
| Pharmaceutics International, Inc. | 29 Sep 2021 | Human Drugs | On file |
| Bell-More Labs, Inc. | 7 Jun 2021 | Human Drugs | View 483 → |
| Alembic Pharmaceuticals Limited | 13 Mar 2020 | Human Drugs | On file |
| Megafine Pharma (P) Limited | 6 Mar 2020 | Human Drugs | On file |
Sites inspected
Pharmaceutics International, Inc.Hunt Valley, United States1 insp.
Pharmaceutics International, Inc.Cockeysville, United States1 insp.
Bell-More Labs, Inc.Hampstead, United States1 insp.
Alembic Pharmaceuticals LimitedPanchmahal, India1 insp.
Megafine Pharma (P) LimitedLakhamapur, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Marcellinus D Dordunoo3 shared
Kathleen M Jordan2 shared
Viviana Matta2 shared
Cynthia Jim2 shared
Joseph T Madak1 shared
Amy S Graf1 shared
Sarah E Rhoades1 shared
Wayne D Mcgrath1 shared
Michele Perry-Williams1 shared
Aurora-Miha Trifanov1 shared
Full investigator report
Get the verbatim findings behind Shirshendu K Deb's 20 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site